Invention Grant
- Patent Title: CD133 epitopes
- Patent Title (中): CD133表位
-
Application No.: US13826737Application Date: 2013-03-14
-
Publication No.: US09382308B2Publication Date: 2016-07-05
- Inventor: John S. Yu , Keith L. Black , Gentao Liu
- Applicant: Cedars-Sinai Medical Center
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Fish & Richardson P.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K35/15 ; C07K14/705 ; C07K7/06 ; A61K45/06
Abstract:
An immunogen includes an isolated peptide of 800 amino acid residues or fewer having the amino sequence ILSAFSVYV (SEQ ID NO: 1) with four or fewer amino acid substitutions, a superagonist variant of SEQ ID NO: 1, or an amino acid sequence having the formula: (I/K/T/V/M)-L-(S/L)-(A/E/N/D/Q)-(F/V)-(S/M/V/I)-(V/D/R/G/H)-Y-(V/I/L) (SEQ ID NO: 13). The immunogens can be used in compositions and in the treatment of disorders.
Public/Granted literature
- US20130183378A1 CD133 Epitopes Public/Granted day:2013-07-18
Information query
